{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T04:50:53Z","timestamp":1744087853454},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00482-012-1278-6","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T00:27:12Z","timestamp":1358900832000},"page":"7-19","source":"Crossref","is-referenced-by-count":13,"title":["Chronische nichttumorbedingte Schmerzen"],"prefix":"10.1007","volume":"27","author":[{"given":"R.","family":"Scharnagel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sch\u00fctze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Heineck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gossrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sabatowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"key":"1278_CR1","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2012) Langzeitanwendung von Opioiden bei nicht-tumorbedingten Schmerzen (LONTS). http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/041-003l.pdf. Zugegriffen: 6.\u00a0Juli 2012"},{"key":"1278_CR2","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2010) Medikamentenabh\u00e4ngigkeit (Sedativa-Hypnotika, Analgetika, Psychostimulantien). http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/076-009_S2_Medikamentenabhaengigkeit_05-2006_05-2011.pdf. Zugegriffen: 18.\u00a0Oktober 2010"},{"key":"1278_CR3","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft (2012) Abh\u00e4ngigkeitspotenzial von Pregabalin (Lyrica\u00ae) (Aus der UAW-Datenbank). http:\/\/www.akdae.de\/Arzneimittelsicherheit\/Bekanntgaben\/Archiv\/2011\/20110128.html. Zugegriffen: 5.\u00a0September 2012"},{"key":"1278_CR4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1213\/ANE.0b013e318209d320","volume":"112","author":"Ashburn","year":"2011","unstructured":"Ashburn MA, Slevin KA, Messina J, Xie\u00a0F (2011) The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain. Anesth Analg 112:693\u2013702","journal-title":"Anesth Analg"},{"key":"1278_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2007.03.028","volume":"129","author":"Ballantyne","year":"2007","unstructured":"Ballantyne JC, LaForge KS (2007) Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129:235\u2013255","journal-title":"Pain"},{"key":"1278_CR6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1360-0443.2010.03014.x","volume":"105","author":"Bell","year":"2010","unstructured":"Bell J (2010) The global diversion of pharmaceutical drugs: opiate treatment and the diversion of pharmaceutical opiates: a clinician\u2019s perspective. Addiction 105:1531\u20131537","journal-title":"Addiction"},{"key":"1278_CR7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","volume":"305","author":"Bohnert","year":"2011","unstructured":"Bohnert AS, Valenstein M, Bair MJ et\u00a0al (2011) Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 305:1315\u20131321","journal-title":"JAMA"},{"key":"1278_CR8","doi-asserted-by":"crossref","unstructured":"Bradshaw DH, Empy C, Davis P, Lipschitz D et\u00a0al (2008) Trends in funding for research on pain: a report on the National Institutes Of Health grant awards over the years 2003\u20132007. J\u00a0Pain 9:1077\u20131087","DOI":"10.1016\/j.jpain.2008.09.008"},{"key":"1278_CR9","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (2012) Sachverst\u00e4ndigenausschuss f\u00fcr Bet\u00e4ubungsmittel. http:\/\/www.bfarm.de\/DE\/Bundesopiumstelle\/BtM\/sachverst\/Protokolle\/Ergebnisse_38.html. Zugegriffen: 22.\u00a0August 2012"},{"key":"1278_CR10","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S et\u00a0al (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13:e58\u2013e68","journal-title":"Lancet Oncol"},{"key":"1278_CR11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0269216310392102","volume":"25","author":"Caraceni","year":"2011","unstructured":"Caraceni A, Pigni A, Brunelli C (2011) Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project. Palliat Med 25:402\u2013409","journal-title":"Palliat Med"},{"key":"1278_CR12","doi-asserted-by":"crossref","unstructured":"Chapman CR, Lipschitz DL, Angst MS et\u00a0al (2010) Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J\u00a0Pain 11:807\u2013829","DOI":"10.1016\/j.jpain.2010.02.019"},{"key":"1278_CR13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1503\/cmaj.100548","volume":"182","author":"Chou","year":"2010","unstructured":"Chou R (2010) What we still don\u2019t know about treating chronic noncancer pain with opioids. CMAJ 182:881\u2013882","journal-title":"CMAJ"},{"key":"1278_CR14","doi-asserted-by":"crossref","unstructured":"Chou R, Ballantyne JC, Fanciullo GJ et\u00a0al (2009) Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J\u00a0Pain 10:147\u2013159","DOI":"10.1016\/j.jpain.2008.10.007"},{"key":"1278_CR15","doi-asserted-by":"crossref","unstructured":"Chou R, Clark E, Helfand M (2003) Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J\u00a0Pain Symptom Manage 26:1026\u20131048","DOI":"10.1016\/j.jpainsymman.2003.03.003"},{"key":"1278_CR16","doi-asserted-by":"crossref","unstructured":"Chou R, Fanciullo GJ, Fine PG et\u00a0al (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J\u00a0Pain 10:113\u2013130","DOI":"10.1016\/j.jpain.2008.10.008"},{"key":"1278_CR17","doi-asserted-by":"crossref","unstructured":"Chou R, Fanciullo GJ, Fine PG et\u00a0al (2009) Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J\u00a0Pain 10:131\u2013146","DOI":"10.1016\/j.jpain.2008.10.009"},{"key":"1278_CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pain.2008.03.021","volume":"139","author":"Cicero","year":"2008","unstructured":"Cicero TJ, Lynskey M, Todorov A et\u00a0al (2008) Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain 139:127\u2013135","journal-title":"Pain"},{"key":"1278_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","volume":"81","author":"Compton","year":"2006","unstructured":"Compton WM, Volkow ND (2006) Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 81:103\u2013107","journal-title":"Drug Alcohol Depend"},{"key":"1278_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejpain.2008.06.014","volume":"13","author":"Davies","year":"2009","unstructured":"Davies AN, Dickman A, Reid C et\u00a0al (2009) The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 13:331\u2013338","journal-title":"Eur J Pain"},{"key":"1278_CR21","unstructured":"Deutsche Hauptstelle f\u00fcr Suchtfragen e.\u00a0V. (Hrsg) (2012) Jahrbuch Sucht 2012. Pabst Science, Lengerich"},{"key":"1278_CR22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1503\/cmaj.090784","volume":"181","author":"Dhalla","year":"2009","unstructured":"Dhalla IA, Mamdani MM, Sivilotti ML et\u00a0al (2009) Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 181:891\u2013896","journal-title":"CMAJ"},{"key":"1278_CR23","doi-asserted-by":"crossref","first-page":"d5142","DOI":"10.1136\/bmj.d5142","volume":"343","author":"Dhalla","year":"2011","unstructured":"Dhalla IA, Persaud N, Juurlink DN (2011) Facing up to the prescription opioid crisis. BMJ 343:d5142. DOI: 10.1136\/bmj.d5142.:d5142","journal-title":"BMJ"},{"key":"1278_CR24","unstructured":"Dilling H, Freyberger HJ (Hrsg) (2008) Taschenf\u00fchrer zur ICD-10-Klassifikation psychischer St\u00f6rungen. Huber, Bern"},{"key":"1278_CR25","unstructured":"DIMDI (Hrsg) (2012) ICD-10-GM 2012 Systematisches Verzeichnis. Deutscher \u00c4rzte-Verlag, K\u00f6ln"},{"key":"1278_CR26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","volume":"152","author":"Dunn","year":"2010","unstructured":"Dunn KM, Saunders KW, Rutter CM et\u00a0al (2010) Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 152:85\u201392","journal-title":"Ann Intern Med"},{"key":"1278_CR27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1526-4637.2006.00200.x","volume":"8","author":"Edlund","year":"2007","unstructured":"Edlund MJ, Sullivan M, Steffick D et\u00a0al (2007) Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Med 8:647\u2013656","journal-title":"Pain Med"},{"key":"1278_CR28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1526-4637.2010.00939.x","volume":"11","author":"Farrar","year":"2010","unstructured":"Farrar JT, Messina J, Xie F, Portenoy\u00a0RK (2010) A novel 12-week study, with three randomized, double-blind placebo-controlled periods to evaluate fentanyl buccal tablets for the relief of breakthrough pain in opioid-tolerant patients with noncancer-related chronic pain. Pain Med 11:1313\u20131327","journal-title":"Pain Med"},{"key":"1278_CR29","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1111\/j.1526-4637.2009.00666.x","volume":"10","author":"Fine","year":"2009","unstructured":"Fine PG, Mahajan G, McPherson ML (2009) Long-acting opioids and short-acting opioids: appropriate use in chronic pain management. Pain Med 10(Suppl\u00a02):S79\u201388","journal-title":"Pain Med"},{"key":"1278_CR30","doi-asserted-by":"crossref","unstructured":"Fine PG, Messina J, Xie F et\u00a0al (2010) Long-term safety and tolerability of fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic pain: an 18-month study. J\u00a0Pain Symptom Manage 40:747\u2013760","DOI":"10.1016\/j.jpainsymman.2010.02.009"},{"key":"1278_CR31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1526-4637.2010.00891.x","volume":"11","author":"Fine","year":"2010","unstructured":"Fine PG, Narayana A, Passik SD (2010) Treatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management. Pain Med 11:1024\u20131036","journal-title":"Pain Med"},{"key":"1278_CR32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1526-4637.2007.00370.x","volume":"9","author":"Fishbain","year":"2008","unstructured":"Fishbain DA, Cole B, Lewis J et\u00a0al (2008) What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse\/addiction and\/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 9:444\u2013459","journal-title":"Pain Med"},{"key":"1278_CR33","doi-asserted-by":"crossref","unstructured":"Fleming MF, Balousek SL, Klessig CL et\u00a0al (2007) Substance use disorders in a primary care sample receiving daily opioid therapy. J\u00a0Pain 8:573\u2013582","DOI":"10.1016\/j.jpain.2007.02.432"},{"key":"1278_CR34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1503\/cmaj.100187","volume":"182","author":"Furlan","year":"2010","unstructured":"Furlan AD, Reardon R, Weppler C (2010) Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ 182:923\u2013930","journal-title":"CMAJ"},{"key":"1278_CR35","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1111\/j.1526-4637.2009.00668.x","volume":"10","author":"Gilson","year":"2009","unstructured":"Gilson AM, Kreis PG (2009) The burden of the nonmedical use of prescription opioid analgesics. Pain Med 10(Suppl\u00a02):S89\u2013100","journal-title":"Pain Med"},{"key":"1278_CR36","first-page":"e13","volume":"5","author":"Gomes","year":"2011","unstructured":"Gomes T, Juurlink DN, Dhalla IA et\u00a0al (2011) Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med 5:e13\u2013e22","journal-title":"Open Med"},{"key":"1278_CR37","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ejpain.2008.11.006","volume":"13","author":"Hamunen","year":"2009","unstructured":"Hamunen K, Paakkari P, Kalso E (2009) Trends in opioid consumption in the Nordic countries 2002\u20132006. Eur J Pain 13:954\u2013962","journal-title":"Eur J Pain"},{"key":"1278_CR38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.neuro.29.051605.113009","volume":"29","author":"Hyman","year":"2006","unstructured":"Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565\u2013598","journal-title":"Annu Rev Neurosci"},{"key":"1278_CR39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1472-6963-6-46","volume":"6","author":"Ives","year":"2006","unstructured":"Ives TJ, Chelminski PR, Hammett-Stabler CA et\u00a0al (2006) Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 6:46","journal-title":"BMC Health Serv Res"},{"key":"1278_CR40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejpain.2004.11.009","volume":"9","author":"Jage","year":"2005","unstructured":"Jage J (2005) Opioid tolerance and dependence\u2014do they matter? Eur J Pain 9:157\u2013162","journal-title":"Eur J Pain"},{"key":"1278_CR41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neubiorev.2003.11.007","volume":"27","author":"Koob","year":"2004","unstructured":"Koob GF, Ahmed SH, Boutrel B et\u00a0al (2004) Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27:739\u2013749","journal-title":"Neurosci Biobehav Rev"},{"key":"1278_CR42","unstructured":"Landesapothekenkammer Baden-W\u00fcrtemberg (2012) http:\/\/www.lak-bw.de\/infocenter\/apothekenpraxis\/vorsicht-gefaelschte-rezepte.html. Zugegriffen: 17.\u00a0Oktober 2012"},{"key":"1278_CR43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00482-008-0716-y","volume":"22","author":"Maier","year":"2008","unstructured":"Maier C (2008) Auch Sucht ist eine Krankheit. Schmerz 22:639\u2013643","journal-title":"Schmerz"},{"key":"1278_CR44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.36076\/ppj.2010\/13\/401","volume":"13","author":"Manchikanti","year":"2010","unstructured":"Manchikanti L, Fellows B, Ailinani H et\u00a0al (2010) Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 13:401\u2013435","journal-title":"Pain Physician"},{"key":"1278_CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.36076\/ppj.2006\/9\/57","volume":"9","author":"Manchikanti","year":"2006","unstructured":"Manchikanti L, Manchukonda R, Damron KS et\u00a0al (2006) Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 9:57\u201360","journal-title":"Pain Physician"},{"key":"1278_CR46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pain.2008.03.011","volume":"136","author":"Markman","year":"2008","unstructured":"Markman JD (2008) Not so fast: the reformulation of fentanyl and breakthrough chronic non-cancer pain. Pain 136:227\u2013229","journal-title":"Pain"},{"key":"1278_CR47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","volume":"146","author":"Martell","year":"2007","unstructured":"Martell BA, O\u2019Connor PG, Kerns RD et\u00a0al (2007) Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 146:116\u2013127","journal-title":"Ann Intern Med"},{"key":"1278_CR48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-152-2-201001190-00012","volume":"152","author":"McLellan","year":"2010","unstructured":"McLellan AT, Turner BJ (2010) Chronic noncancer pain management and opioid overdose: time to change prescribing practices. Ann Intern Med 152:123\u2013124","journal-title":"Ann Intern Med"},{"key":"1278_CR49","unstructured":"Bundes\u00e4rztekammer in Zusammenarbeit mit der Arzneimittelkommission der deutschen \u00c4rzteschaft (Hrsg) (o\u00a0J) Medikamente \u2013 sch\u00e4dlicher Gebrauch und Abh\u00e4ngigkeit. Leitfaden f\u00fcr die \u00e4rztliche Praxis. http:\/\/www.bundesaerztekammer.de\/downloads\/LeitfadenMedAbhaengigkeit.pdf. Zugegriffen: 6.\u00a0Juli 2012"},{"key":"1278_CR50","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cncr.10249","volume":"94","author":"Mercadante","year":"2002","unstructured":"Mercadante S, Radbruch L, Caraceni A et\u00a0al (2002) Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 94:832\u2013839","journal-title":"Cancer"},{"key":"1278_CR51","doi-asserted-by":"crossref","unstructured":"Michna E, Ross EL, Hynes WL et\u00a0al (2004) Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J\u00a0Pain Symptom Manage 28:250\u2013258","DOI":"10.1016\/j.jpainsymman.2004.04.007"},{"key":"1278_CR52","first-page":"CD006605","volume":"Rev","author":"Noble","year":"2010","unstructured":"Noble M, Treadwell JR, Tregear SJ et\u00a0al (2010) Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev:CD006605","journal-title":"Cochrane Database Syst"},{"key":"1278_CR53","doi-asserted-by":"crossref","unstructured":"Okie S (2010) A flood of opioids, a rising tide of deaths. N\u00a0Engl J Med 363:1981\u20131985","DOI":"10.1056\/NEJMp1011512"},{"key":"1278_CR54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1024\/0939-5911\/a000044","volume":"56","author":"Pabst","year":"2010","unstructured":"Pabst A, Piontek D, Kraus L, M\u00fcller\u00a0S (2010) Substanzkonsum und substanzbezogene St\u00f6rungen. Ergebnisse des Epidemiologischen Suchtsurveys 2009. Sucht 56:327\u2013336","journal-title":"Sucht"},{"key":"1278_CR55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0025-6196(11)60748-9","volume":"84","author":"Passik","year":"2009","unstructured":"Passik SD (2009) Issues in long-term opioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc 84:593\u2013601","journal-title":"Mayo Clin Proc"},{"key":"1278_CR56","doi-asserted-by":"crossref","unstructured":"Passik SD, Hays L, Eisner N et\u00a0al (2006) Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J\u00a0Pain Palliat Care Pharmacother 20:5\u201313","DOI":"10.1080\/J354v20n02_03"},{"key":"1278_CR57","doi-asserted-by":"crossref","unstructured":"Passik SD, Messina J, Golsorkhi A et\u00a0al (2011) Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J\u00a0Pain Symptom Manage 41:116\u2013125","DOI":"10.1016\/j.jpainsymman.2010.03.012"},{"key":"1278_CR58","unstructured":"Porada S (2011) REMS; red tape, or a remedy for opioid abuse? J\u00a0Fam Pract 60:S55\u2013S62"},{"key":"1278_CR59","doi-asserted-by":"crossref","unstructured":"Portenoy RK, Bennett DS, Rauck R et\u00a0al (2006) Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J\u00a0Pain 7:583\u2013591","DOI":"10.1016\/j.jpain.2006.02.003"},{"key":"1278_CR60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1185\/030079906X162818","volume":"23","author":"Portenoy","year":"2007","unstructured":"Portenoy RK, Messina J, Xie F et\u00a0al (2007) Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study. Curr Med Res Opin 23:223\u2013233","journal-title":"Curr Med Res Opin"},{"key":"1278_CR61","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00482-009-0839-9","volume":"23","author":"Reinecke","year":"2009","unstructured":"Reinecke H, Sorgatz H (2009) S3-Leitlinie LONTS. Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen. Schmerz 23:440\u2013447","journal-title":"Schmerz"},{"key":"1278_CR62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0376-8716(01)00127-2","volume":"64","author":"Roset","year":"2001","unstructured":"Roset PN, Farre M, de la Torre R et\u00a0al (2001) Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend 64:285\u2013298","journal-title":"Drug Alcohol Depend"},{"key":"1278_CR63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/pmt.12.17","volume":"2","author":"Sabatowski","year":"2012","unstructured":"Sabatowski R (2012) Critical issues in cancer pain management. Pain Manage 2:201\u2013204","journal-title":"Pain Manage"},{"key":"1278_CR64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tips.2004.12.007","volume":"26","author":"Samaha","year":"2005","unstructured":"Samaha AN, Robinson TE (2005) Why does the rapid delivery of drugs to the brain promote addiction? Trends Pharmacol Sci 26:82\u201387","journal-title":"Trends Pharmacol Sci"},{"key":"1278_CR65","doi-asserted-by":"crossref","unstructured":"Savage SR, Joranson DE, Covington EC et\u00a0al (2003) Definitions related to the medical use of opioids: evolution towards universal agreement. J\u00a0Pain Symptom Manage 26:655\u2013667","DOI":"10.1016\/S0885-3924(03)00219-7"},{"key":"1278_CR66","unstructured":"Schubert I, Ihle P, Sabatowski R (2012) Zunahme der Opioidverordnungen in Deutschland zwischen 2000 und 2010. Eine Studie auf Basis von Krankenkassendaten. Dtsch Arztebl Int (im Druck)"},{"key":"1278_CR67","doi-asserted-by":"crossref","unstructured":"Schwabe U, Paffrath D (Hrsg) (2011) Arzneiverordnungsreport 2011. Springer, Berlin","DOI":"10.1007\/978-3-642-21992-4"},{"key":"1278_CR68","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.clinthera.2007.04.007","volume":"29","author":"Simpson","year":"2007","unstructured":"Simpson DM, Messina J, Xie F et\u00a0al (2007) Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 29:588\u2013601","journal-title":"Clin Ther"},{"key":"1278_CR69","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00115-004-1828-y","volume":"76","author":"Soyka","year":"2005","unstructured":"Soyka M, Queri S, Kufner H et\u00a0al (2005) Wo verstecken sich 1,9\u00a0Millionen Medikamentenabh\u00e4ngige? Nervenarzt 76:72\u201377","journal-title":"Nervenarzt"},{"key":"1278_CR70","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archinternmed.2011.2156","volume":"172","author":"Sullivan","year":"2012","unstructured":"Sullivan MD, Ballantyne JC (2012) What are we treating with long-term opioid therapy? Arch Intern Med 172:433\u2013434","journal-title":"Arch Intern Med"},{"key":"1278_CR71","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinte.166.19.2087","volume":"166","author":"Sullivan","year":"2006","unstructured":"Sullivan MD, Edlund MJ, Zhang L et\u00a0al (2006) Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 166:2087\u20132093","journal-title":"Arch Intern Med"},{"key":"1278_CR72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1526-4637.2007.00298.x","volume":"8","author":"Taylor","year":"2007","unstructured":"Taylor DR, Webster LR, Chun SY et\u00a0al (2007) Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ). Pain Med 8:281\u2013288","journal-title":"Pain Med"},{"key":"1278_CR73","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","volume":"70","author":"Treede","year":"2008","unstructured":"Treede RD, Jensen TS, Campbell JN et\u00a0al (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70:1630\u20131635","journal-title":"Neurology"},{"key":"1278_CR74","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/jama.2011.369","volume":"305","author":"Volkow","year":"2011","unstructured":"Volkow ND, McLellan TA (2011) Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA 305:1346\u20131347","journal-title":"JAMA"},{"key":"1278_CR75","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.2011.401","volume":"305","author":"Volkow","year":"2011","unstructured":"Volkow ND, McLellan TA, Cotto JH et\u00a0al (2011) Characteristics of opioid prescriptions in 2009. JAMA 305:1299\u20131301","journal-title":"JAMA"},{"key":"1278_CR76","doi-asserted-by":"crossref","unstructured":"Webster LR, Messina J, Xie F et\u00a0al (2011) Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough pain. J\u00a0Opioid Manag 7:297\u2013308","DOI":"10.5055\/jom.2011.0071"},{"key":"1278_CR77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pain.2009.05.006","volume":"145","author":"Weisner","year":"2009","unstructured":"Weisner CM, Campbell CI, Ray GT et\u00a0al (2009) Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain 145:287\u2013293","journal-title":"Pain"},{"key":"1278_CR78","unstructured":"Wissenschaftliches Institut der AOK (2012) http:\/\/www.wido.de\/fileadmin\/wido\/downloads\/pdf_arzneimittel\/wido_arz_avr2012pk_0912.pdf. Zugegriffen: 17.\u00a0Oktober 2012"},{"key":"1278_CR79","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/0269216310385601","volume":"25","author":"Zeppetella","year":"2011","unstructured":"Zeppetella G (2011) Opioids for the management of breakthrough cancer pain in adults: a systematic review undertaken as part of an EPCRC opioid guidelines project. Palliat Med 25:516\u2013524","journal-title":"Palliat Med"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-012-1278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-012-1278-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-012-1278-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T14:31:36Z","timestamp":1644157896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-012-1278-6"}},"subtitle":["Langzeitbehandlung mit schnell freisetzenden und kurz wirksamen Opioiden im Kontext von Missbrauch und Abh\u00e4ngigkeit"],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1007\/s00482-012-1278-6","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}